Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies

Thrombosis and Haemostasis

Volumn 75, Issue 5, 1996, Pages 721-724

  Pengo, V ^a   Biasiolo, A ^a   Brocco, T ^a   Tonetto, S ^a   Ruffatti, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOSIS;

EID: 0029896410     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650355     Document Type: Article

References (33)

1. Fiumara NJ. Biologic false positive reaction for syphilis. N Engl J Med 1963; 268: 402-5.
2. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemostas Thromb 1972; 1: 75-95.
3. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CB, Loizou S, Hughes GRV. Anticardiolipin antibodies: detection by radioimmu-noassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-4.
4. Thiagarajan P, Shapiro SS, De Marco L. Monoclonal immunoglobulin Mλ coagulation inhibitor with phospholipid specificity. J Clin Invest 1980; 66: 397-405.
5. Harris EN, Gharavi AE, Tincani A, Chan JKH, Englert H, Mantelli P, Allegro F, Balestrieri G, Hughes GVR. Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol 1985; 155-62.
6. Pengo V, Thiagarajan P, Shapiro SS, Heine MJ. Immunologic specificity and mechanism of action of IgG lupus anticoagulant. Blood 1987; 70: 69-76.
7. 2-Glycoprotein-I (Apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
8. Galli M, Comfurius P, Maassen C, Hemker HC, De Baets MH, Van Brieda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7.
9. Matsuura E, Igarashi Y, Fujimoto M, Ichikava K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-8.
10. 2-Glycoprotein-I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-62.
11. 2-Glycoprotein-I in the absence of phospholipids. J Immunol 1995; 154: 954-60.
12. 2-Glycoprotein-I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34.
13. 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
14. 2-Glycoprotein-I inhibit phospholipid dependent coagulation reaction. Thromb Haemost 1993; 70: 598-602.
15. 2-glycoprotein I. J Clin Invest 1992; 90: 1100-4.
16. Matsuura E, Igashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, Yasuda T, Koike T. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148: 3885-91.
17. Fleck RA, Rapaport SI, Visajia Mohan Rao L. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-9.
18. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus antico-agulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-32.
19. Janoff AS, Rauch J. The structural specificity of antiphospholipid antibodies in autoimmune disease. Chem Phys Lipids 1986; 40: 315-32.
20. Harris EN. Syndrome of the Black swan. Br J Rheumatol 1987; 26: 324-6.
21. Asherson RA. A "primary" antiphospholipid syndrome. J Rheumatol 1988; 15: 1742-4.
22. 2-glycoprotein I anti-bodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.
23. Oosting JD, Derksen RHWM, Bobbink IWG, Hackeng TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipid with prothrombin, protein C or protein S: an explanation for their pathogenetic mechanism? Blood 1993; 81: 2618-25.
24. Biasiolo A, Pengo V. Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis. Blood Coag Fibrinol 1993, 4: 425-8.
25. Harris EN, Gharavi AE, Patel SP, Hughes GVR. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-22.
26. Thiagarajan P, Pengo V, Shapiro SS. The use of dilute Russell Viper Venom Time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-73.
27. Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on human platelets. J Biol Chem 1978; 253: 6908-16.
28. 2-glycoprotein I antigenicity induced by phospholipid binding. Thromb Haemost 1993; 69: 361-5.
29. 2-glycoprotein I as an antigen. J Immunol Meth 1991; 143: 223-9.
30. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-Lupus Anticoagulant syndrome. Blood 1983; 61: 684-92.
31. Edson JR, Vogt JM, Hasegawa DK. Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors. Blood 1984; 64: 807-16.
32. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992, 326: 800-6.
33. Pengo V, Biasiolo A, Fior MG. Binding of autoimmune cardiolipin-reactive antibodies to heparin: a mechanism of thrombosis? Thromb Res 1995; 78: 371-8.